75
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Novel fast dissolving freeze dried sublingual baicalin tablets for enhanced hepatoprotective effect: in-vitro characterization, cell viability, and in-vivo evaluation

, , , , , & show all
Pages 371-382 | Received 08 Nov 2023, Accepted 05 Apr 2024, Published online: 13 Apr 2024

References

  • Ahmed S, Islam MS, Ullah B, Kanti Biswas S, Samad Azad MA, Hossain MS. 2020. A review article on pharmaceutical analysis of pharmaceutical industry according to pharmacopoeias. Orient J Chem. 36(1):01–10. doi: 10.13005/ojc/360101.
  • Ahmed IS, Nafadi MM, Fatahalla FA. 2006. Formulation of a fast-dissolving ketoprofen tablet using freeze-drying in blisters technique. Drug Dev Ind Pharm. 32(4):437–442. doi: 10.1080/03639040500528913.
  • Ahmed IS, Rashed HM, Fayez H, Farouk F, Shamma RN. 2020. Nanoparticle-mediated dual targeting: an approach for enhanced baicalin delivery to the liver. Pharmaceutics. 12(2):107. doi: 10.3390/pharmaceutics12020107.
  • Ahmed IS, Shamma RN, Shoukri RA. 2013. Development and optimization of lyophilized orally disintegrating tablets using factorial design. Pharm Dev Technol. 18(4):935–943. doi: 10.3109/10837450.2011.619543.
  • Akhavan Mahdavi S, Jafari SM, Assadpoor E, Dehnad D. 2016. Microencapsulation optimization of natural anthocyanins with maltodextrin, gum Arabic and gelatin. Int J Biol Macromol. 85:379–385. doi: 10.1016/j.ijbiomac.2016.01.011.
  • Alboraie M, Youssef N, Sherief AF, Afify S, Wifi MN, Omran D, Hafez E, Omar H, Eltabbakh M, Abdellah M, et al. 2019. Egyptian liver library: an indexed database for liver disease evidence in Egypt. Arab J Gastroenterol. 20(2):109–113. doi: 10.1016/j.ajg.2019.05.004.
  • Ali R, Saad I, Shamma RN. 2009. In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets. Eur J Pharm Biopharm. 73(1):162–171. doi: 10.1016/j.ejpb.2009.04.005.
  • Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. 2021. Advances in oral drug delivery. Front Pharmacol. 12:618411. doi: 10.3389/fphar.2021.618411.
  • Asrani SK, Devarbhavi H, Eaton J, Kamath PS. 2018. Burden of liver diseases in the world. J Hepatol. 70(1):151–171.
  • Aulton ME, Taylor KM. 2018. Aulton’s pharmaceutics: the design and manufacture of medicines.
  • Besnier E, Clavier T, Tonon MC, Pelletier G, Dureuil B, Castel H, Compère V. 2018. Anesthetic drugs modulate feeding behavior and hypothalamic expression of the POMC polypeptide precursor and the NPY neuropeptide. BMC Anesthesiol. 18(1):96. doi: 10.1186/s12871-018-0557-x.
  • Braun RJ, Parrott EL. 1972. Influence of viscosity and solubilization on dissolution rate. J Pharm Sci. 61(2):175–178. doi: 10.1002/jps.2600610206.
  • British Pharmacopeia. 2023. Deutscher Apotheker Verlag, 2022.
  • Corveleyn S, Remon JP. 1997. Formulation and production of rapidly disintegrating tablets by lyophilisation using hydrochlorothiazide as a model drug. Int J Pharm. 152(2):215–225. doi: 10.1016/S0378-5173(97)00092-6.
  • Corveleyn S, Remon JP. 1998. Formulation of a lyophilized dry emulsion tablet for the delivery of poorly soluble drugs. Int J Pharm. 166(1):65–74. doi: 10.1016/S0378-5173(98)00024-6.
  • Cui L, Sune E, Song J, Wang J, Bin Jia X, Zhang ZH. 2016. Characterization and bioavailability study of baicalin-mesoporous carbon nanopowder solid dispersion, Pharmacogn Mag. 12:326–332.
  • De Vries J, De Jong J, Lock FM, Van Bree L, Mullink H, Veldhuizen RW, 1984. Protection against paracetamol-induced hepatotoxicity by acetylsalicylic acid in rats. Toxicology, 30(4): 297–304.
  • Dinda B, Dinda S, DasSharma S, Banik R, Chakraborty A, Dinda M. 2017. Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders. Eur J Med Chem. 131:68–80. doi: 10.1016/j.ejmech.2017.03.004.
  • Elnaggar YSR, Massik MAEl, Abdallah OY, Ebian AER. 2010. Maltodextrin : a Novel Excipient Used in Sugar-Based Orally Disintegrating Tablets and Phase Transition Process. AAPS PharmSciTech. 11(2):645–651.
  • Gupta A, Hunt RL, Shah RB, Sayeed VA, Khan MA. 2009. Disintegration of highly soluble immediate release tablets: a surrogate for dissolution. AAPS PharmSciTech. 10(2):495–499. doi: 10.1208/s12249-009-9227-0.
  • Haider M, Hassan MA, Ahmed IS, Shamma R. 2018. Thermogelling platform for baicalin delivery for versatile biomedical applications. Mol Pharm. 15(8):3478–3488. doi: 10.1021/acs.molpharmaceut.8b00480.
  • Hu Z, Guan Y, Hu W, Xu Z, Ishfaq M. 2022. An overview of pharmacological activities of baicalin and its aglycone baicalein: new insights into molecular mechanisms and signaling pathways. Iran J Basic Med Sci. 25:14–26.
  • Huang HL, Wang YJ, Zhang QY, Liu B, Wang FY, Li JJ, Zhu RZ. 2012. Hepatoprotective effects of baicalein against CCl4-induced acute liver injury in mice. World J Gastroenterol. 18(45):6605–6613. doi: 10.3748/wjg.v18.i45.6605.
  • Jakab G, Bogdán D, Mazák K, Deme R, Mucsi Z, Mándity IM, Noszál B, Kállai-Szabó N. 2019. Physicochemical profiling of baicalin along with the development and characterization of cyclodextrin inclusion complexes. AAPS PharmSciTech. 20(8):314.
  • Jakab G, Fülöp V, Bozó T, Balogh E, Kellermayer M, Antal I. 2018. Optimization of quality attributes and atomic force microscopy imaging of reconstituted nanodroplets in baicalin loaded self-nanoemulsifying formulations. Pharmaceutics. 10(4):275. doi: 10.3390/pharmaceutics10040275.
  • Jangid AK, Agraval H, Rai DB, Jain P, Yadav UC, Pooja D, Kulhari H. 2020. Baicalin encapsulating lipid-surfactant conjugate based nanomicelles: preparation, characterization and anticancer activity. Chem Phys Lipids. 233:104978. doi: 10.1016/j.chemphyslip.2020.104978.
  • Kazimierz Gasiorowski 1 GA, Lamer-Zarawska E, Leszek J, Parvathaneni K. 2011. Bharat Bhushan Yendluri, Zofia Błach-Olszewska, Flavones from root of Scutellaria baicalensis Georgi: drugs of the future in neurodegeneration? CNS Neurol Disord Drug Targets. 10(2):184–191.
  • Kennedy JF, Knill CJ, Taylor DW. 1995. Handbook of starch hydrolysis products and their derivatives. Boston: Springer.
  • Khan S, Kataria P, Nakhat P, Yeole P. 2007. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets. AAPS PharmSciTech. 8(2): E127–E133.
  • Lee H, Kang R, Yoon Y. 2010. SH21B, an anti-obesity herbal composition, inhibits fat accumulation in 3T3-L1 adipocytes and high fat diet-induced obese mice through the modulation of the adipogenesis pathway. J Ethnopharmacol. 127(3):709–717. doi: 10.1016/j.jep.2009.12.002.
  • Mahmoud AA, Salah S. 2012. Fast relief from migraine attacks using fast-disintegrating sublingual zolmitriptan tablets. Drug Dev Ind Pharm. 38(6):762–769. doi: 10.3109/03639045.2011.625949.
  • Mitchell SJ, Hilmer SN. 2010. Drug-induced liver injury in older adults. Ther Adv Drug Saf. 1(2):65–77. doi: 10.1177/2042098610386281.
  • Muriel P, Rivera-Espinoza Y. 2008. Beneficial drugs for liver diseases. J Appl Toxicol. 28(2):93–103. doi: 10.1002/jat.1310.
  • Odeyemi S, Dewar J. 2019. Repression of acetaminophen-induced hepatotoxicity in HepG2 Cells by polyphenolic compounds from lauridia tetragona (L.f.) R.H. Archer. Molecules. 24(11):2118. doi: 10.3390/molecules24112118.
  • Panraksa P, Udomsom S, Rachtanapun P, Chittasupho C, Ruksiriwanich W, Jantrawut P. 2020. Hydroxypropyl methylcellulose e15: a hydrophilic polymer for fabrication of orodispersible film using syringe extrusion 3d printer. Polymers (Basel). 12(11):2666. doi: 10.3390/polym12112666.
  • Parkash V, Maan S, Yadav SK, Jogpal V. 2011. Fast disintegrating tablets: opportunity in drug delivery system. J Adv Pharm Technol Res. 2(4):223–235.
  • Patro Sisinthy S, Prasad Panda B. 2016. Formulation and evaluation of cetirizine HCL mouth fast dissolving tablets. Der Pharmacia Lettre. 3(4):63–70.
  • Peh KK, Wong CF. 1999. Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties. J Pharm Pharm Sci. 2:53–61.
  • Schiermeier S, Schmidt PC. 2002. Fast dispersible ibuprofen tablets. Eur J Pharm Sci. 15(3):295–305. doi: 10.1016/s0928-0987(02)00011-8.
  • Shi-Ying J, Jin H, Shi-Xiao J, Qing-Yuan LV, Jin-Xia B, Chen HG, Rui-Sheng L, Wei WU, Hai-Long Y. 2014. Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method. Chin J Nat Med. 12(1):71–80. doi: 10.1016/S1875-5364(14)60012-1.
  • Suk KT, Kim DJ. 2012. Drug-induced liver injury: present and future. Clin Mol Hepatol. 18(3):249–257. doi: 10.3350/cmh.2012.18.3.249.
  • Suzihaque M, Irfan H, Ibrahim U. 2017. A study on friability, hardness and fiber content analysis of fiber enriched milk tablet. IOP Conf Ser: mater Sci Eng. 206:012038. doi: 10.1088/1757-899X/206/1/012038.
  • Toniutto P. 2022. Special issue “New therapies of liver diseases”. J Clin Med. 11(7):1798.
  • Uhl P, Fricker G, Haberkorn U, Mier W. 2014. Current status in the therapy of liver diseases. Int J Mol Sci. 15(5):7500–7512. doi: 10.3390/ijms15057500.
  • Vargas-Mendoza N, Madrigal-Santillán E, Morales-González Á, Esquivel-Soto J, Esquivel-Chirino C, García-Luna y González-Rubio MG, Gayosso-de-Lucio JA, Morales-González JA. 2014. Hepatoprotective effect of silymarin. WJH. 6(3):144–149. doi: 10.4254/wjh.v6.i3.144.
  • Vichai V, Kirtikara K. 2006. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 1(3):1112–1116. doi: 10.1038/nprot.2006.179.
  • Wei Y, Guo J, Zheng X, Wu J, Zhou Y, Yu Y, Ye Y, Zhang L, Zhao L. 2014. Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes. Int J Nanomed. 9:3623–3630. doi: 10.2147/IJN.S66312.
  • Wei Y, Liang J, Zheng X, Pi C, Liu H, Yang H, Zou Y, Ye Y, Zhao L. 2017. Lung-targeting drug delivery system of baicalin-loaded nanoliposomes: development, biodistribution in rabbits, and pharmacodynamics in nude mice bearing orthotopic human lung cancer. Int J Nanomed. 12:251–261. doi: 10.2147/IJN.S119895.
  • Yang J-Y, Li M, Zhang C-L, Liu D. 2021. Pharmacological properties of baicalin on liver diseases: a narrative review. Pharmacol Rep. 73(5):1230–1239.
  • Yoon E, Babar A, Choudhary M, Kutner M, Pyrsopoulos N. 2016. Acetaminophen-induced hepatotoxicity: a comprehensive update. J Clin Transl Hepatol. 4:131–142.
  • Zaki A, Anwa E, Surini S. 2017. Formulation of a fast-disintegrating tablet using maltodextrin de 10-15 and pregelatinizated cassava starch as expedients. Int J App Pharm. 9:71–73.
  • Zhao L, Wei Y, Huang Y, He B, Zhou Y, Fu J. 2013. Nanoemulsion improves the oral bioavailability of baicalin in rats: in vitro and in vivo evaluation. Int J Nanomed. 8:3769–3779. doi: 10.2147/IJN.S51578.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.